TEC14-Reproducci贸n Humana y Enfermedades Hereditarias y Complejas
Terapias Avanzadas y Tecnolog铆as Biom茅dicas / IBS-TEC14 / Consolidado
Grupo multidisciplinar con clara intenci贸n traslacional. La atenci贸n a los deseos reproductivos de parejas est茅riles centra el campo de actuaci贸n del grupo, ya sea a nivel molecular o cl铆nico. Su investigaci贸n se centra en aumentar la seguridad y calidad de estas t茅cnicas. Aborda aspectos claramente moleculares como receptividad uterina y espermatog茅nesis. Adem谩s, trabaja en aspectos obst茅tricos relacionados con el parto prematuro como su prevenci贸n y tratamiento. En relaci贸n con las enfermedades hereditarias y complejas se centra en enfermedades de base claramente gen茅tica (como poliquistosis renal autos贸mica dominante) o multifactoriales (como c谩ncer hereditario). Abordando su prevenci贸n tanto mediante consejo gen茅tico reproductivo como el estudio de diferentes variantes gen茅ticas.
L铆neas de investigaci贸n
- Avances en parto prematuro
- Bases moleculares de las patolog铆as de la espermatog茅nesis
- Receptividad uterina
- Seguridad de las t茅cnicas de reproducci贸n asistida
- Enfermedades renales hereditarias
- Gen茅tica cl铆nica
Palabras clave
Esterilidad, Parto prematuro, Reproducci贸n asistida, Gen茅tica cl铆nica.
INMACULADA HIGUERAS SERRANO
ALEJANDRA ROBLES FERNANDEZ
BARBARA FOLCH AVI脩O
CELIA TENORIO MU脩OZ
IRENE LEONES BA脩OS
MIRIAM GAMIZ AGUILERA
SEBASTIAN MANZANARES GALAN
ANALUCE CANHA GOUVEIA
GEMMA ALVAREZ CORRAL
ANTONIO QUERO CEBALLOS
SUSANA RUIZ DURAN
SARA GONZALEZ MU脩OZ
ANDREA GUZMAN JIMENEZ
RAFAEL FERNANDEZ CASTILLO
MARIA DEL MAR DEL AGUILA GARCIA
MARIA PAZ CARRILLO BADILLO
BARBARA ROMERO GUADIX
LUIS MARTINEZ NAVARRO
NEREA MOLINA MORALES
MARTA MOLINA ROMERO
ANA ISABEL MORALES GARCIA
NOELIA MORALES RINCON
JUAN MOZAS MORENO
ROGELIO PALOMINO MORALES
MARIA DOLORES PRADOS GARRIDO
ALBERTO PUERTAS PRIETO
LARA MARIA BOSSINI CASTILLO
FRANCISCO DAVID CARMONA LOPEZ
JOSE ANTONIO CASTILLA ALCALA
MIRIAM CERVAN MARTIN
ANA CLAVERO GILABERT
RAFAEL JOSE ESTEBAN DE LA ROSA
JUAN FONTES JIMENEZ
MARIA CARMEN GONZALVO LOPEZ
MARTIN LOPEZ DE LA TORRE CASARES
SIGNE ALTMAE
ROCIO SANCHEZ RUIZ
ANTONIO MIGUEL POYATOS ANDUJAR
Gut bacteriome and mood disorders in women with PCOS
HUMAN REPRODUCTION, 2024;
FI:6; D1
An unbiased approach of molecular characterization of the endometrium: toward defining endometrial-based infertility
HUMAN REPRODUCTION, 2024;
FI:6; D1
Changes in environmental exposures over decades may influence the genetic architecture of severe spermatogenic failure
HUMAN REPRODUCTION, 2024;
FI:6; D1
Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis
HUMAN REPRODUCTION UPDATE, 2024;
FI:14,8; D1
A Randomized Controlled Clinical Trial Testing Effects of Lademirsen on Kidney Function Decline in Adults with Alport Syndrome
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024;
FI:8,5; D1
Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis
JOURNAL OF AUTOIMMUNITY, 2023;
FI:12,8; D1
Nanoassemblies of acetylcholinesterase and ?-lactamase immobilized on magnetic nanoparticles as biosensors to detect pollutants in water
TALANTA, 2023;
FI:6,1; D1
Study of SARS-CoV-2 in semen from asymptomatic donors with the presence of virus in nasopharyngeal swabs
REPRODUCTIVE BIOMEDICINE ONLINE, 2023;
FI:4; Q1
Endometrial whole metabolome profile at the receptive phase: influence of Mediterranean Diet and infertility
FRONTIERS IN ENDOCRINOLOGY, 2023;
FI:5,2; Q1
Microenvironment of the Lower Reproductive Tract: Focus on the Cervical Mucus Plug
SEMINARS IN REPRODUCTIVE MEDICINE, 2023;
FI:2,7; Q2
Allosteric Communication in the Multifunctional and Redox NQO1 Protein Studied by Cavity-Making Mutations
ANTIOXIDANTS, 2022;
FI:7,675; D1
Genitourinary microbial screening for all infertile men?
NATURE REVIEWS UROLOGY, 2022;
FI:16,43; D1
Human endometrial cell-type-specific RNA sequencing provides new insights into the embryo-endometrium interplay
HUMAN REPRODUCTION OPEN, 2022;
FI:7,13; D1
The mid-secretory endometrial transcriptomic landscape in endometriosis: a meta-analysis
HUMAN REPRODUCTION OPEN, 2022;
FI:7,13; D1
A GWAS in Idiopathic/Unexplained Infertile Men Detects a Genomic Region Determining Follicle-Stimulating Hormone Levels
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022;
FI:6,134; Q1
Analysing endometrial microbiome: methodological considerations and recommendations for good practice
HUMAN REPRODUCTION, 2021;
FI:6,918; D1
Assessing the testicular sperm microbiome: a low-biomass site with abundant contamination
REPRODUCTIVE BIOMEDICINE ONLINE, 2021;
FI:3,828; Q1
Cardiorespiratory fitness in children with overweight/obesity: Insights into the molecular mechanisms
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2021;
FI:4,221; Q1
Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study)
BMJ OPEN, 2021;
FI:2,692; Q2
Characteristics of Heart Rate Tracings in Preterm Fetus
MEDICINA-LITHUANIA, 2021;
FI:2,43; Q2
Cross-disorder analysis of endometriosis and its comorbid diseases reveals shared genes and molecular pathways and proposes putative biomarkers of endometriosis
REPRODUCTIVE BIOMEDICINE ONLINE, 2020;
FI:3,218; Q1
Deficiency of the onco-miRNA cluster, miR-106b similar to 25, causes oligozoospermia and the cooperative action of miR-106b similar to 25 and miR-17 similar to 92 is required to maintain male fertility
MOLECULAR HUMAN REPRODUCTION, 2020;
FI:3,636; Q1
DNA methylation in infants with low and high body fatness
BMC GENOMICS, 2020;
FI:3,594; Q2
An integrated model with classification criteria to predict vaginal delivery success after cesarean section
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020;
FI:1,737; Q3
Comparison of MDRD and the old CKD-EPI equations with the new CKD-EPI equations in kidney transplant patients when glomerular filtration rate is measured with 51Cr-EDTA
NEFROLOGIA, 2020;
FI:1,544; Q4
The seminal microbiome in health and disease
NATURE REVIEWS UROLOGY, 2019;
FI:9,333; D1
Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy
PHARMACEUTICS, 2019;
FI:4,773; D1
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
NATURE COMMUNICATIONS, 2019;
FI:11,878; D1
Identification of a 3 ‘-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
ARTHRITIS & RHEUMATOLOGY, 2019;
FI:9,002; D1
Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells
SCIENTIFIC REPORTS, 2019;
FI:4,011; Q1
Can we improve risk communication about non-invasive prenatal testing?
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018;
FI:4,876; D1
Decisions about aneuploidy screening: why women’s reasons are important
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018;
FI:4,876; D1
Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample
PATIENT EDUCATION AND COUNSELING, 2018;
FI:2,785; D1
Living in the past: The impact of victimization memory on threat perceptions
MEMORY STUDIES, 2018;
FI:0,922; D1
Reliability and agreement on embryo assessment: 5 years of an external quality control programme
REPRODUCTIVE BIOMEDICINE ONLINE, 2018;
FI:2,967; Q1
Cassandra’s Regret: The Psychology of Not Wanting to Know
PSYCHOLOGICAL REVIEW, 2017;
FI:7,638; D1
Language and motor skills in siblings of children with autism spectrum disorder: A meta-analytic review
AUTISM RESEARCH, 2017;
FI:3,765; D1
Infants at-risk for autism spectrum disorder: Patterns of vocalizations at 14 months
AUTISM RESEARCH, 2017;
FI:3,765; D1
Designing Visual Aids That Promote Risk Literacy: A Systematic Review of Health Research and Evidence-Based Design Heuristics
HUMAN FACTORS, 2017;
FI:2,219; Q1
Inter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse
PLOS ONE, 2017;
FI:2,806; Q1
Improving risk literacy in surgeons
PATIENT EDUCATION AND COUNSELING, 2016;
FI:2,232; D1
Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHREaEuro
HUMAN REPRODUCTION, 2016;
FI:4,621; D1
Measuring Graph Literacy without a Test: A Brief Subjective Assessment
MEDICAL DECISION MAKING, 2016;
FI:2,908; Q1
Type D personality is related to severity of acute coronary syndrome in patients with recurrent cardiovascular disease
BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2016;
FI:2,895; Q1
Commentary: Risky decision-making is associated with residential choice in healthy older adults
FRONTIERS IN PSYCHOLOGY, 2016;
FI:2,463; Q1
Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program
FERTILITY AND STERILITY, 2015;
FI:4,59; D1
Simple But Powerful Health Messages for Increasing Condom Use in Young Adults
JOURNAL OF SEX RESEARCH, 2015;
FI:2,695; D1
Neural mechanisms underlying urgent and evaluative behaviors: An fMRI study on the interaction of automatic and controlled processes
HUMAN BRAIN MAPPING, 2015;
FI:5,969; D1
Is Patients’ Numeracy Related to Physical and Mental Health?
MEDICAL DECISION MAKING, 2015;
FI:3,24; Q1
The Impact of Depression on Self-Other Discrepancies in Decision Making
JOURNAL OF BEHAVIORAL DECISION MAKING, 2015;
FI:2,069; Q1
Descifrando el componente inmunol贸gico de patrones extremos de infertilidad masculina: un enfoque multi贸mico (IMMFERT)
Financiador: AGENCIA ESTATAL DE INVESTIGACI脫N
N煤mero de expediente: PID2023-152215OB-I00
Tiempo de ejecuci贸n: 01/09/2024 - 31/12/2028
IP: FRANCISCO DAVID CARMONA LOPEZ
Atlas transcripcional de la infertilidad masculina debida a alteraciones de la espermatogenesis
Financiador: UNIVERSIDAD DE GRANADA
N煤mero de expediente: C-CTS-273-UGR23
Tiempo de ejecuci贸n: 01/01/2024 - 31/12/2026
IP: LARA MARIA BOSSINI CASTILLO
Endo-Map: Microbial mapping and host-microbe interactions in pathogenesis of endometriosis and concomitant infertility
Financiador: AGENCIA ESTATAL DE INVESTIGACI脫N
N煤mero de expediente: PID2021-127280OB-I00
Tiempo de ejecuci贸n: 01/09/2022 - 31/08/2025
IP: SIGNE ALTMAE
Estudio de las causas gen茅ticas de la infertilidad masculina debida a fallo espermatog茅nico
Financiador: CONSEJER脥A DE TRANSFORMACI脫N ECON脫MICA, INDUSTRIA, CONOCIMIENTO Y UNIVERSIDADES
N煤mero de expediente: PY20_00212
Tiempo de ejecuci贸n: 04/10/2021 - 30/06/2023
IP: FRANCISCO DAVID CARMONA LOPEZ
Caracterizaci贸n molecular de entidades subcl铆nicas de la infertilidad masculina (AZOON脫MICA2)
Financiador: AGENCIA ESTATAL DE INVESTIGACI脫N
N煤mero de expediente: PID2020-120157RB-I00
Tiempo de ejecuci贸n: 01/09/2021 - 31/08/2024
IP: ROGELIO PALOMINO MORALES
Bases gen茅ticas y moleculares del fallo espermatog茅nico severo
Financiador: UNIVERSIDAD DE GRANADA
N煤mero de expediente: CTS-584
Tiempo de ejecuci贸n: 01/07/2021 - 30/09/2023
IP: FRANCISCO DAVID CARMONA LOPEZ
An谩lisis de la Utilidad de la Transferencia Diferida en Un Programa de Fecundaci贸n In Vitro Con pol铆tica de Embri贸n 脷nico
Financiador: CONSEJER脥A DE SALUD
N煤mero de expediente: PI-0353-2016
Tiempo de ejecuci贸n: 01/01/2017 - 31/12/2019
IP: ANA CLAVERO GILABERT
Microbiota uterina en endometriosis: potenciales biomarcadores en enfermedad y del resultado en el tratamiento de infertilidad (MENDO)
Financiador: UNIVERSIDAD DE GRANADA
N煤mero de expediente: B-CTS-500-UGR18
Tiempo de ejecuci贸n: 01/01/2020 - 31/12/2021
IP: SIGNE ALTMAE
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of the NOX1/4 Inhibitor Setanaxib in Patients With Alport Syndrome
Financiador: MEDPACE CLINICAL RESEARCH LLC
Tipo de prueba: ENSAYO CL脥NICO CON MEDICAMENTOS
Tiempo de ejecuci贸n: 31/01/2024 - 30/01/2025
IP: RAFAEL JOSE ESTEBAN DE LA ROSA
Ensayo multic茅ntrico de fase IIa, aleatorizado, doble ciego, de grupos cruzados y controlado con placebo para evaluar la seguridad y eficacia de BAY 2395840 en pacientes con dolor neurop谩tico diab茅tico.
Financiador: BAYER AG
Tipo de prueba: ENSAYO CLINICO COMERCIAL
Tiempo de ejecuci贸n: 24/01/2022 - 22/11/2022
IP: MARTIN LOPEZ DE LA TORRE CASARES
Optimizaci贸n del manejo antenatal de mujeres con amenaza de parto pret茅rmino mediante modelos de predicci贸n: estudio cl铆nico randomizado multic茅ntrico abierto
Financiador: FUNDACI脫 CL脥NIC PER A LA RECERCA BIOM脠DICA
Tipo de prueba: ENSAYO CLINICO INDEPENDIENTE
Tiempo de ejecuci贸n: 16/12/2021 - 30/06/2023
IP: MARIA PAZ CARRILLO BADILLO
Ensayo en Fase III sobre la Eficacia y Seguridad del metilbardoxolona en Pacientes con Enfermedad Poliqu铆stica Renal Autos贸mica Dominante. FALCON
Financiador: REATA PHARMACEUTICALS INC
Tipo de prueba: ENSAYO CLINICO COMERCIAL
Tiempo de ejecuci贸n: 02/03/2021 - 30/06/2023
IP: RAFAEL JOSE ESTEBAN DE LA ROSA
Estudio multicentrico, abierto, propectivo, aleatorizado para explorar la morbimortalidad en pacientes dializados con hemodialisis extendida en comparacion con la hemodiafiltracion en linea. Estudio Mother HDx
Financiador: FUNDACION SENEFRO
Tipo de prueba: INV. CLINICA PRODUCTO SANITARIO INDEP.
Tiempo de ejecuci贸n: 07/02/2020 - 30/03/2022
IP: MARIA DOLORES PRADOS GARRIDO
Ensayo en fase 2, aleatorizado, doble ciego, controlado con placebo para evaluar la seguridad, eficacia, farmacodin谩mica y farmacocin茅tica de SAR339375 administrado como inyecci贸n subcut谩nea semanalmente en pacientes con s铆n
Financiador: GENZYME CORPORATION
Tipo de prueba: ENSAYO CLINICO COMERCIAL
Tiempo de ejecuci贸n: 15/10/2020 - 31/08/2023
IP: RAFAEL JOSE ESTEBAN DE LA ROSA
The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT).
Financiador: LILLY, S.A.
Tipo de prueba: ENSAYO CLINICO COMERCIAL
Tiempo de ejecuci贸n: 13/07/2020 - 30/10/2024
IP: MARTIN LOPEZ DE LA TORRE CASARES
Estudio posautorizacion de seguridad multicentrico y no intervencionista de 6 a帽os de duracion realizado en pacientes a los que se ha recetado JINARC debido a poliquitosis renal autosomica dominante
Financiador: OTSUKA PHARMACEUTICAL EUROPE LTD
Tipo de prueba: ESTUDIO POSAUTORIZACION COMERCIAL
Tiempo de ejecuci贸n: 03/11/2020 - 30/09/2029
IP: ANA ISABEL MORALES GARCIA